Bloomberg, Law Reports, Risk & Compliance

In 2005, the U.S. Supreme Court issues a seven page opinion that reshaped the world of securities litigation.  In Dura Pharmaceuticals, Inc. v. Broudo, the Supreme Court enhanced the “loss causation” requirement applicable to at least some securities plaintiffs, specifically those alleging “fraud on the market” cases.  

The full article can be found here.

Jump to Page